Umeå universitets logga

umu.sePublikationer
Driftstörningar
Just nu har vi driftstörningar på sök-portalerna på grund av hög belastning. Vi arbetar på att lösa problemet, ni kan tillfälligt mötas av ett felmeddelande.
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • apa-6th-edition.csl
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Potentially inappropriate drug treatment among older people with cognitive impairment
Umeå universitet, Medicinska fakulteten, Institutionen för integrativ medicinsk biologi (IMB).
2022 (Engelska)Doktorsavhandling, sammanläggning (Övrigt vetenskapligt)Alternativ titel
Potentiellt olämplig läkemedelsbehandling bland äldre personer med kognitiv svikt (Svenska)
Abstract [en]

Background: The aging process contributes to alterations in organ systems, which lead to an increased risk for chronic conditions. Drug treatment is an important strategy in the management of chronic conditions; however, pharmacokinetic and pharmacodynamic alterations contribute to increased sensitivity to drug effects. This sensitivity is even more pronounced among older people with major neurocognitive disorder. Nevertheless, this group of people is often exposed to potentially inappropriate drug treatment associated with serious adverse drug reactions.

Aim: To identify patterns of potentially inappropriate drug treatment and factors associated with this type of drug treatment among older people with cognitive impairment to enable further improvement of drug treatment and diminish the risk of adverse drug reactions among this vulnerable group of people.

Method: Explicit criteria were utilized to identify inappropriate prescriptions based on renal function, potentially inappropriate medications according to age and clinically relevant drug-drug interactions among older people with cognitive impairment admitted to two hospitals in Northern Sweden. The first two studies included 428 people and the third study 458 people. Medical records were used as the data source. Moreover, explicit criteria were used to identify potentially inappropriate medications according to age among 1,881 and 1,305 nursing home residents in Västerbotten county in 2007 and 2013, respectively. The association between the length of nursing home stay and the use of potentially inappropriate medications were investigated based on information in questionnaires. Finally, the use of potentially inappropriate medications according to age were investigated three years pre- and post-diagnosis of major neurocognitive disorder among 67,226 older people registered in the Swedish registry for cognitive/dementia disorders.

Results: Every tenth of the people admitted to hospital had at least one inappropriate prescription based on their estimated renal function. Moreover, 40.9% had at least one potentially inappropriate medication and 43.2% had at least one clinically relevant drug-drug interaction. Pharmacodynamic interactions were found to be the most common type. Increasing number of prescribed medications was significantly associated with having at least one potentially inappropriate medication according tovage and at least one clinically relevant drug-drug interaction, respectively. Moreover, potentially inappropriate medications were common among nursing home residents but had decreased 2013 compared to 2007 and were only to a lesser extent associated with the length of stay. In the nationwide study population, it was found that potentially inappropriate medications according to age were overall low and decreased continuously three years pre-diagnosis until three years post-diagnosis of major neurocognitive disorder. Consequently, the use of potentially inappropriate medications was found to be significantly lower post- diagnosis except when concerning antipsychotic drug treatment, which was significantly higher post-diagnosis when compared with the pre- diagnosis period.

Conclusion: Potentially inappropriate drug treatment is common among older people with cognitive impairment admitted to the hospitals in Västerbotten regardless of their type of living. Increasing number of medications was significantly associated with potentially inappropriate medications and clinically relevant drug-drug interactions. The decreasing trend of potentially inappropriate medications among nursing home residents and among older people with a major neurocognitive disorder is positive and indicates an increased awareness of potentially inappropriate drug treatment in healthcare.

Ort, förlag, år, upplaga, sidor
Umeå: Umeå University , 2022. , s. 115
Serie
Umeå University medical dissertations, ISSN 0346-6612 ; 2176
Nyckelord [en]
Older people, major neurocognitive disorder, cognitive impairment, potentially inappropriate medications, drug-drug interactions, renal function, adverse drug reactions, nursing homes, time trends
Nationell ämneskategori
Geriatrik
Forskningsämne
klinisk farmakologi
Identifikatorer
URN: urn:nbn:se:umu:diva-194381ISBN: 978-91-7855-765-3 (tryckt)ISBN: 978-91-7855-766-0 (digital)OAI: oai:DiVA.org:umu-194381DiVA, id: diva2:1655675
Disputation
2022-06-03, NAT.D.360, Naturvetarhuset, Umeå, 09:00 (Svenska)
Opponent
Handledare
Tillgänglig från: 2022-05-09 Skapad: 2022-05-03 Senast uppdaterad: 2022-05-04Bibliografiskt granskad
Delarbeten
1. Inappropriate Prescription and Renal Function Among Older Patients with Cognitive Impairment
Öppna denna publikation i ny flik eller fönster >>Inappropriate Prescription and Renal Function Among Older Patients with Cognitive Impairment
2016 (Engelska)Ingår i: Drugs and aging, ISSN 1170-229X, Vol. 33, nr 12, s. 889-899Artikel i tidskrift, Editorial material (Refereegranskat) Published
Abstract [en]

Background Older people are more sensitive to drugs and adverse drug reactions than younger people because of age-related physiological changes such as impaired renal function. As people with dementia are particularly vulnerable to the effects of drugs, it is especially important to evaluate the dosages of renally cleared medications in this group.

Objective The aim of this study was to estimate the prevalence of impaired renal function and inappropriate prescriptions on the basis of renal function among older patients with dementia or cognitive impairment. Methods The medical records of 428 patients aged ≥65 years who were admitted to two hospitals in northern Sweden were reviewed and renally cleared medications were identified. The Cockcroft–Gault equation was used to evaluate renal function. Doses were evaluated according to the Geriatric Dosage Handbook.

Results Renal function was impaired (estimated glomerular filtration rate <60 ml/min) in 65.4 % of the study population. Impaired renal function was associated with increasing age. Among 547 prescriptions identified as renally cleared medications, 9.1 % were inappropriate based on the patient’s renal function; 13.5 % of the 326 patients prescribed renally cleared medications had inappropriate prescriptions. Inappropriate prescriptions were more common among patients living in nursing homes.

Conclusions Impaired renal function is common and inappropriate prescription is prevalent among old people with cognitive impairment in northern Sweden. Continuous consideration of renal function is important when prescribing medications to this group.

Ort, förlag, år, upplaga, sidor
Springer, 2016
Nationell ämneskategori
Farmaceutiska vetenskaper
Identifikatorer
urn:nbn:se:umu:diva-126825 (URN)10.1007/s40266-016-0408-8 (DOI)000388987000004 ()27734278 (PubMedID)2-s2.0-84991107254 (Scopus ID)
Tillgänglig från: 2016-10-14 Skapad: 2016-10-14 Senast uppdaterad: 2023-03-23Bibliografiskt granskad
2. An evaluation of the prevalence of potentially inappropriate medications in older people with cognitive impairment living in Northern Sweden using the EU(7)-PIM list
Öppna denna publikation i ny flik eller fönster >>An evaluation of the prevalence of potentially inappropriate medications in older people with cognitive impairment living in Northern Sweden using the EU(7)-PIM list
2017 (Engelska)Ingår i: European Journal of Clinical Pharmacology, ISSN 0031-6970, E-ISSN 1432-1041, Vol. 73, nr 6, s. 735-742Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Purpose As people get older, their sensitivity to drugs and adverse drug reactions can increase due to pharmacokinetic and pharmacodynamic changes. Older people with dementia are a particularly vulnerable group of people. They are at an increased risk of being prescribed potentially inappropriate medications, which may lead to harmful consequences. The aim of this study was to investigate the prevalence of potentially inappropriate medications among older patients with cognitive impairment. Methods Medical records for patients aged ≥65 years admitted to two hospitals in Northern Sweden were reviewed. Potentially inappropriate medications were identified using the EU(7)-PIM list as an identification tool. Results Of 428 patients included in the study, 40.9% had one or more potentially inappropriate medication prescribed. The most commonly represented potentially inappropriate medication classes were hypnotics and sedatives, cardiovascular drugs and laxatives. The most commonly involved potentially inappropriate medications were zopiclone, digoxin and sodium picosulfate. There was an association seen between having a higher number of medications prescribed and having one or more potentially inappropriate medication. Conclusion Potentially inappropriate medications are prevalent among older people with cognitive impairment living in Northern Sweden. It is important to continuously evaluate the need for potentially inappropriate medications in this patient group, in order to prevent adverse drug reactions, especially among those who have a higher number of medications prescribed.

Nyckelord
Older people, Cognitive impairment, Potentially inappropriate medications, EU(7)-PIM list
Nationell ämneskategori
Geriatrik
Forskningsämne
geriatrik
Identifikatorer
urn:nbn:se:umu:diva-131328 (URN)10.1007/s00228-017-2218-2 (DOI)000400999200010 ()28246889 (PubMedID)2-s2.0-85014016241 (Scopus ID)
Tillgänglig från: 2017-02-12 Skapad: 2017-02-12 Senast uppdaterad: 2023-03-24Bibliografiskt granskad
3. Clinically relevant drug-drug interactions among elderly people with dementia
Öppna denna publikation i ny flik eller fönster >>Clinically relevant drug-drug interactions among elderly people with dementia
2018 (Engelska)Ingår i: European Journal of Clinical Pharmacology, ISSN 0031-6970, E-ISSN 1432-1041, Vol. 74, nr 10, s. 1351-1360Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Purpose: Increased numbers of drugs and changes in pharmacokinetic and pharmacodynamic parameters among elderly people contribute to increased prevalence of adverse drug reactions. Drug-drug interactions (DDIs) are an important reason for admission to hospital and elderly people with dementia are particularly vulnerable. The aims of the present study were to assess the occurrence and characteristics of clinically relevant DDIs and to investigate potential risk factors associated with DDIs among elderly people with dementia.

Methods: People 65 years with dementia, admitted to two hospitals in Northern Sweden, were included. The medical records of 458 patients were reviewed. Clinically relevant DDIs were identified using the Janusmed interactions database. Pharmacological classification was conducted using Stockley's classification system.

Results: A total of 401 DDIs were identified among 43.2% of the study population, of which 98.5% had interactions that may require dose adjustment and 7.6% had drug combinations that should be avoided. Pharmacodynamic interactions were most common, of which furosemide-citalopram (n=35) were most frequently observed. Omeprazol-citalopram (n=25) was the most common drug combination among pharmacokinetic interactions. Citalopram and warfarin were the most commonly involved drug substances. An association was found between a higher number of medications being prescribed and having at least one DDI.

Conclusion: Clinically relevant drug-drug interactions are prevalent among elderly people with dementia living in Northern Sweden. Drug-drug interactions should be identified in order to manage and prevent adverse outcomes. This is particularly important among this group of people especially when multiple medications are being prescribed.

Ort, förlag, år, upplaga, sidor
Springer Berlin/Heidelberg, 2018
Nyckelord
Drug-drug interactions (DDIs), Drug-related problems (DRPs), Adverse drug reactions (ADRs), Adverse drug events (ADEs), Elderly people, Dementia
Nationell ämneskategori
Farmakologi och toxikologi
Identifikatorer
urn:nbn:se:umu:diva-152244 (URN)10.1007/s00228-018-2514-5 (DOI)000444387700015 ()29967921 (PubMedID)2-s2.0-85049564142 (Scopus ID)
Forskningsfinansiär
DemensförbundetVästerbottens läns landstingSvenska läkaresällskapet
Tillgänglig från: 2018-10-04 Skapad: 2018-10-04 Senast uppdaterad: 2023-03-24Bibliografiskt granskad
4. Potentially inappropriate medications in relation to length of nursing home stay among older adults
Öppna denna publikation i ny flik eller fönster >>Potentially inappropriate medications in relation to length of nursing home stay among older adults
2022 (Engelska)Ingår i: BMC Geriatrics, E-ISSN 1471-2318, Vol. 22, nr 1, artikel-id 70Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Background: To investigate the use of potentially inappropriate medications and their relation to the length of nursing home stay among older adults.

Methods: Questionnaire surveys using the Multi-Dimensional Dementia Assessment scale were sent out to all nursing homes in Västerbotten county in northern Sweden in 2007 and 2013. In total, 3186 adults (1881 from 2007 and 1305 from 2013) ≥65 years old were included and 71.8% of those had cognitive impairment. Potentially inappropriate medications were identified using drug-specific quality indicators according to Swedish National Board of Health and Welfare.

Results: Potentially inappropriate medications were used by 48.0% of the 2007 study sample and by 28.4% of the 2013 study sample. The prevalence of glibenclamide use 2007 and antipsychotic drug use 2013 increased linearly (β = 0.534E− 3, 95% CI: 0.040E− 3-0.103E− 2, p = 0.034 and β = 0.155E− 2, 95% CI: 0.229E− 3-0.288E− 2, p = 0.022, respectively) with the length of nursing home stay. No significant association was found between the prevalence of propiomazine, codeine, long-acting benzodiazepines, anticholinergics, NSAIDs, tramadol or the total use of potentially inappropriate medications and the length of stay in nursing homes in 2007 or 2013. Antipsychotics were the most commonly prescribed of the drug classes investigated and used by 22.6% of the residents 2007 and by 16.0% of the residents 2013.

Conclusions: These results indicate that treatment with potentially inappropriate medications is common among older adults living in nursing homes, but it seems to be related to the length of nursing home stay only to a smaller extent. Drug treatment should regularly be reviewed and followed-up among nursing home residents regardless of their length of nursing home stay, in order to prevent unnecessary adverse events.

Ort, förlag, år, upplaga, sidor
BioMed Central, 2022
Nyckelord
Length of stay, Major neurocognitive disorders, Nursing homes, Older adults, Potentially inappropriate medications
Nationell ämneskategori
Geriatrik
Identifikatorer
urn:nbn:se:umu:diva-192152 (URN)10.1186/s12877-021-02639-3 (DOI)000745585600001 ()35065614 (PubMedID)2-s2.0-85123466647 (Scopus ID)
Forskningsfinansiär
Region VästerbottenDemensförbundet
Tillgänglig från: 2022-02-04 Skapad: 2022-02-04 Senast uppdaterad: 2024-07-04Bibliografiskt granskad
5. Potentially inappropriate medications pre and post-diagnosis of major neurocognitive disorders among older people in Sweden - A register-based, six-year longitudinal study
Öppna denna publikation i ny flik eller fönster >>Potentially inappropriate medications pre and post-diagnosis of major neurocognitive disorders among older people in Sweden - A register-based, six-year longitudinal study
(Engelska)Manuskript (preprint) (Övrigt vetenskapligt)
Nationell ämneskategori
Geriatrik
Identifikatorer
urn:nbn:se:umu:diva-194377 (URN)
Tillgänglig från: 2022-05-03 Skapad: 2022-05-03 Senast uppdaterad: 2022-05-03

Open Access i DiVA

fulltext(1486 kB)386 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 1486 kBChecksumma SHA-512
37cd54085f4f1f1d651131d48dbe8e66bff813c1de0b32649c8855097a78807d8ea47bf85d5afde2e55c91b81d00953d8c142d0cda9d18e623e3bea7f3f911b6
Typ fulltextMimetyp application/pdf
spikblad(131 kB)60 nedladdningar
Filinformation
Filnamn SPIKBLAD01.pdfFilstorlek 131 kBChecksumma SHA-512
a06bb25c82b55f3d8cd379602f981b5f17ceb469fd61809793bbb598c13b2759f6106d33165fd84246350c4ae6907a37b452a1fd5c7bf3e6cd865bd17ca5a471
Typ spikbladMimetyp application/pdf

Person

Sönnerstam, Eva

Sök vidare i DiVA

Av författaren/redaktören
Sönnerstam, Eva
Av organisationen
Institutionen för integrativ medicinsk biologi (IMB)
Geriatrik

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 386 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

isbn
urn-nbn

Altmetricpoäng

isbn
urn-nbn
Totalt: 881 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • apa-6th-edition.csl
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf